{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:40:01Z","timestamp":1760028001574,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004321","name":"Shire (IE)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12913-017-2274-4","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T07:34:45Z","timestamp":1495438485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria"],"prefix":"10.1186","volume":"17","author":[{"given":"Nicola","family":"Bonner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Panter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rich","family":"Sinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Moellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"2274_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000335621","volume":"97","author":"M Lerch","year":"2012","unstructured":"Lerch M. Drug-induced angioedema. Chem Immunol Allergy. 2012;97:98\u2013105. doi:\n10.1159\/000335621\n\n.","journal-title":"Chem Immunol Allergy"},{"issue":"8","key":"2274_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/archinte.164.8.910","volume":"164","author":"M Cicardi","year":"2004","unstructured":"Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med. 2004;164(8):910\u20133. doi:\n10.1001\/archinte.164.8.910\n\n.","journal-title":"Arch Intern Med"},{"issue":"3","key":"2274_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.anai.2014.12.007","volume":"114","author":"JA Bernstein","year":"2015","unstructured":"Bernstein JA, Moellman JJ, Collins SP, Hart KW, Lindsell CJ. Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department. Ann Allergy Asthma Immunol. 2015;114(3):245\u20139. doi:\n10.1016\/j.anai.2014.12.007\n\n.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"2274_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0003489414543069","volume":"124","author":"NJ Chan","year":"2015","unstructured":"Chan NJ, Soliman AMS. Angiotensin Converting Enzyme Inhibitor-Related Angioedema: Onset, Presentation, and Management. Ann Otol Rhinol Laryngol. 2015;124(2):89\u201396. doi:\n10.1177\/0003489414543069\n\n.","journal-title":"Ann. Otol. Rhinol. Laryngol"},{"issue":"2","key":"2274_CR5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.annemergmed.2014.07.014","volume":"65","author":"LM Lewis","year":"2015","unstructured":"Lewis LM, Graffeo C, Crosley P, Klausner HA, Clark CL, Frank A, et al. Ecallantide for the Acute Treatment of Angiotensin-Converting Enzyme Inhibitor\u2013Induced Angioedema: A Multicenter, Randomized, Controlled Trial. Ann Emerg Med. 2015;65(2):204\u201313.","journal-title":"Ann Emerg Med"},{"issue":"6","key":"2274_CR6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1527-5299.2002.01529.x","volume":"8","author":"DA Sica","year":"2002","unstructured":"Sica DA, Black HR. Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy. Congest Heart Fail. 2002;8(6):334\u201341.","journal-title":"Congest Heart Fail"},{"issue":"8","key":"2274_CR7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00002018-200124080-00004","volume":"24","author":"A Agostoni","year":"2001","unstructured":"Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24(8):599\u2013606.","journal-title":"Drug Saf"},{"issue":"3","key":"2274_CR8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0194-5998(99)70182-8","volume":"121","author":"E Ishoo","year":"1999","unstructured":"Ishoo E, Shah UK, Grillone GA, Stram JR, Fuleihan NS. Predicting airway risk in angioedema: staging system based on presentation. Otolaryngol Head Neck Surg. 1999;121(3):263\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"7","key":"2274_CR9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s001340050413","volume":"23","author":"R Agah","year":"1997","unstructured":"Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med. 1997;23(7):793\u20136.","journal-title":"Intensive Care Med"},{"issue":"4","key":"2274_CR10","first-page":"244","volume":"97","author":"C Cupido","year":"2007","unstructured":"Cupido C, Rayner B. Life-threatening angio-oedema and death associated with the ACE inhibitor enalapril. SAfrMedJ. 2007;97(4):244\u20135.","journal-title":"SAfrMedJ"},{"issue":"4","key":"2274_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/acem.12341","volume":"21","author":"JJ Moellman","year":"2014","unstructured":"Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA, et al. A Consensus Parameter for the Evaluation and Management of Angioedema in the Emergency Department. Acad Emerg Med. 2014;21(4):469\u201384. doi:\n10.1111\/acem.12341\n\n.","journal-title":"Acad Emerg Med"},{"issue":"1","key":"2274_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","volume":"60","author":"NJ Brown","year":"1996","unstructured":"Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60(1):8\u201313. doi:\n10.1016\/S0009-9236(96)90161-7\n\n.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2274_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11882-011-0238-z","volume":"12","author":"M Vasekar","year":"2012","unstructured":"Vasekar M, Craig TJ. ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep. 2012;12(1):72\u20138. doi:\n10.1007\/s11882-011-0238-z\n\n.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"2274_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","volume":"100","author":"A Banerji","year":"2008","unstructured":"Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo Jr CA. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100(4):327\u201332. doi:\n10.1016\/S1081-1206(10)60594-7\n\n.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9117","key":"2274_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","volume":"351","author":"J Nussberger","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet. 1998;351(9117):1693\u20137. doi:\n10.1016\/S0140-6736(97)09137-X\n\n.","journal-title":"Lancet"},{"issue":"8","key":"2274_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM200208223470820","volume":"347","author":"J Nussberger","year":"2002","unstructured":"Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med. 2002;347(8):621\u20132. doi:\n10.1056\/NEJM200208223470820\n\n.","journal-title":"N Engl J Med"},{"issue":"3","key":"2274_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.annemergmed.2010.03.032","volume":"56","author":"M Bas","year":"2010","unstructured":"Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med. 2010;56(3):278\u201382. doi:\n10.1016\/j.annemergmed.2010.03.032\n\n.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"2274_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.amjcard.2011.11.014","volume":"109","author":"JR Roberts","year":"2012","unstructured":"Roberts JR, Lee JJ, Marthers DA. Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic. Am J Cardiol. 2012;109(5):774\u20135. doi:\n10.1016\/j.amjcard.2011.11.014\n\n.","journal-title":"Am J Cardiol"},{"key":"2274_CR19","doi-asserted-by":"crossref","first-page":"AB105","DOI":"10.1016\/j.jaci.2010.12.420","volume":"127","author":"DV Perez","year":"2011","unstructured":"Perez DV, Infante S, Marco G, Zubeldia JM. Angioedema induced by angiotensin-converting enzyme inhibitors: two cases of successful traetment with a novel B2 bradykinin antagonist. J Allergy Clin Immunol. 2011;127:AB105.","journal-title":"J Allergy Clin Immunol"},{"volume-title":"Treatment of Angiotensin-Converting Enzyme Inhibitor-Indced Oropharyngeal Angioedema with Icatibant","year":"2011","key":"2274_CR20","unstructured":"Reksten A, editor. Treatment of Angiotensin-Converting Enzyme Inhibitor-Indced Oropharyngeal Angioedema with Icatibant. Istanbul: European Academy of Allergy and Clinical Immunology Congress; 2011."},{"issue":"5","key":"2274_CR21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaad.2010.03.023","volume":"63","author":"PW Schmidt","year":"2010","unstructured":"Schmidt PW, Hirschl MM, Trautinger F. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. J Am Acad Dermatol. 2010;63(5):913\u20134. doi:\n10.1016\/j.jaad.2010.03.023\n\n.","journal-title":"J Am Acad Dermatol"},{"key":"2274_CR22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","volume":"372","author":"M Bas","year":"2015","unstructured":"Bas M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015;372:418\u201325.","journal-title":"N Engl J Med"},{"key":"2274_CR23","unstructured":"Willis GB. Cognitive interviewing: A tool for improving questionnaire design. CA: Sage Publications; 2004."},{"key":"2274_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/0033-295X.87.3.215","volume":"87","author":"KA Ericsson","year":"1980","unstructured":"Ericsson KA, Simon HA. Verbal Reports as Data. Psychol Rev. 1980;87:215\u201351.","journal-title":"Psychol Rev"},{"key":"2274_CR25","first-page":"56","volume-title":"Research Methods for Clinical and Health Psychology","author":"H Joffe","year":"2004","unstructured":"Joffe H, Yardley L. Content and Thematic Analysis. In: Marks DF, Yardley L, editors. Research Methods for Clinical and Health Psychology. London: Sage Publications; 2004. p. 56\u201368."},{"key":"2274_CR26","volume-title":"The Handbook of Visual Analysis","author":"T Leeuwen","year":"2001","unstructured":"Leeuwen T, Jewitt C. The Handbook of Visual Analysis. London: Sage; 2001."},{"issue":"2","key":"2274_CR27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420\u20138.","journal-title":"Psychol Bull"},{"key":"2274_CR28","unstructured":"IBM Corp. IBM SPSS Statistics for Windows, Version 19.0. Armonk, NY: IBM Corp. 2010."},{"key":"2274_CR29","first-page":"248","volume-title":"Psychometric Theory","author":"JC Nunnally","year":"1994","unstructured":"Nunnally JC. The assessment of reliability. In: Bernstein I, editor. Psychometric Theory. New York: McGraw Hill; 1994. p. 248\u201392."},{"issue":"1","key":"2274_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34\u201342. doi:\n10.1016\/j.jclinepi.2006.03.012\n\n.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-017-2274-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T07:34:59Z","timestamp":1495438499000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-017-2274-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2274"],"URL":"https:\/\/doi.org\/10.1186\/s12913-017-2274-4","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2017,5,22]]},"article-number":"366"}}